CVR 27986137Private limited company (ApS)Engroshandel med medicinalvarer og sygeplejeartikler (464610)TilstFounded 13 Aug 2004
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about AH BIOTEC ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
Annual report 2022, average
Gross profit
-5.5K
DKK, annual report 2022
Result
-5.2K
DKK, annual report 2022
Equity
29.1K
DKK, annual report 2022
AH DIAGNOSTICS A/SCVR 26718023, 100% of capital and votes, until 25 Jun 2024
Helle Vibeke Zachountil 8 Mar 2024
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 26718023100% of capital and votes13 Aug 2004 to 25 Jun 2024
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report, the business model and the revenue model a calibrated decision model reading the report's text and the purpose clause, not registered by the company. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
13 Aug 2004 to 13 Nov 2026.
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Gross profit | -11 | -12 | -12 | Not reported | -6 |
| Operating profit | -11 | -12 | -12 | -8 | -6 |
| Result for the year | -10 | -10 | -10 | -7 | -5 |
| Equity | 61 | 51 | 41 | 34 | 29 |
| Total assets | 72 | 63 | 53 | 42 | 35 |
| Employees (average) | Not reported | Not reported | Not reported | 1 | 1 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | 0% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. Group figures (koncern).
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 5 Feb 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 1 Apr 2022
Annual report 2020
1 Jan 2020 to 31 Dec 2020, published 29 Mar 2021
Annual report 2019
1 Jan 2019 to 31 Dec 2019, published 31 Mar 2020
Annual report 2018
1 Jan 2018 to 31 Dec 2018, published 26 Mar 2019
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For AH BIOTEC ApS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 13 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 13 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
13 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Likvidation sluttet, og virksomheden opløst
Likvidatorer:
Fratrådte:
Brian Bjørnholdt, den 25.06.2024.
Likvidation vedtaget 08.03.2024
Likvidatorer:
Tiltrådte:
Brian Bjørnholdt, 8381 Tilst, den 08.03.2024.
Bestyrelse:
Fratrådte:
Niels Stampe Rüdiger, (formand), den 08.03.2024, Helle Vibeke Zacho, den 08.03.2024.
Direktion:
Fratrådte:
Helle Vibeke Zacho, (adm. dir), den 08.03.2024.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Bestyrelse:
Fratrådte:
Helle Sørensen, den 29.08.2023.
Tiltrådte:
Helle Vibeke Zacho, den 29.08.2023.
Direktion:
Fratrådte:
Niels Stampe Rüdiger, den 29.08.2023.
Tiltrådte:
Helle Vibeke Zacho, (adm. dir), den 29.08.2023.
Revision:
Fratrådte:
BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, den 29.03.2022.
Revision:
Fratrådte:
EY Godkendt Revisionspartnerselskab, den 22.12.2021.
Tiltrådte:
CVR-NR. 20222670 BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, Kystvejen 29, 8000 Aarhus C, den 22.12.2021.
Ny adresse: Gammel Viborgvej 11A, 8381 Tilst
Bestyrelse:
Udtrådt af bestyrelsen:
Jørgen Lægaard, den 31.01.2013, Jørn Kildegaard Andersen, den 31.01.2013, Kurt Sigurd Toft, den 31.01.2013.
Indtrådt i bestyrelsen:
Niels Stampe Rüdiger (formand), den 31.01.2013, Helle Sørensen, den 31.01.2013.
Vedtægter ændret:
31.03.2011.
Bestyrelse:
Udtrådt af bestyrelsen:
Asger Bach-Larsen, den 31.03.2011, Mogens Birkebæk, den 31.03.2011.
Indtrådt i bestyrelsen:
Jørn Kildegaard Andersen, den 31.03.2011, Økonomichef Kurt Sigurd Toft, den 31.03.2011.
Revision:
Udtrådt af revisionen:
AP, STATSAUTORISEREDE REVISORER I/S, den 09.09.2009.
Indtrådt i revisionen:
CVR-NR. 26052394 ERNST & YOUNG P/S, Gyngemose Parkvej 50, 2860 Søborg, den 09.09.2009.
Revision:
Udtrådt af revisionen:
REVISIONSFIRMAET VILLY PEDERSEN I/S, den 01.01.2007.
Indtrådt i revisionen:
AP, STATSAUTORISEREDE REVISORER I/S, Olof Palmes Alle 25, 1., 8200 Århus N, den 01.01.2007.
Vedtægter ændret:
25.10.2004.
Stiftelsesdato:
13.08.2004.
Seneste vedtægtsdato:
13.08.2004.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
kontant kr. 125.000,00 til kurs 104,80.
Stifter:
CVR-NR. 26718023 AH DIAGNOSTICS A/S, Runetoften 18, 8210 Århus V, den 13.08.2004.
Bestyrelse:
Direktør Jørgen Lægaard Nielsen (formand), den 13.08.2004, Asger Bach-Larsen, den 13.08.2004, Advokat Mogens Birkebæk, den 13.08.2004.
Direktion:
Niels Stampe Rüdiger, den 13.08.2004.
Selskabet tegnes af direktøren sammen med bestyrelsens formand eller af 2 bestyrelsesmedlemmer i forening.
Revision:
REVISIONSFIRMAET VILLY PEDERSEN I/S, Katrinebjergvej 89F, postboks 1069, 8200 Århus N, den 13.08.2004.
Første regnskabsår:
13.08.2004 - 31.12.2005.
Regnskabsår:
01.01 - 31.12.
1 registered in CVR.
P-number 1010717309Gammel Viborgvej 11, 8381 Tilst